Clinical Trials Logo
  1. Home
  2. Immunology
  3. NCT02017730

To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding in Lung Using PET (Positron Emission Tomography) In Healthy Volunteers

Immunology Clinical Trial

Official title:
An Open-Label Study To Evaluate The Safety and Tolerability Of A Novel LPA1 Receptor Positron Emission Tomography (PET) Ligand [11C]BMT-136088 And To Assess Receptor Occupancy In Human Lung Following Oral Administration Of BMS-986020 In Healthy Subjects

Clinical Trial Summary

The purpose of this study is to assess the safety and tolerability of a novel positron emission tomography (PET) tracer [11C]BMT-136088 in healthy adult subjects for measurement of availability of Lysophosphatidic Acid (LPA1) receptors in the human lung and to use this tracer to assess LPA1 receptor occupancy using [11C]BMT-136088 in the human lung following oral administration of Bristol Myers Squibb (BMS)-986020.

Clinical Trial Description

End point Classification: Pharmacokinetics/Pharmacodynamics ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02017730
Study type Interventional
Source Bristol-Myers Squibb
Contact
Status Completed
Phase Phase 1
Start date January 2014
Completion date January 2015
View Details
See also
  Status Clinical Trial Phase
Completed NCT01698736 - ABO Blood Group Antibody Elimination by a Combination of Semiselective Immunoadsorption Therapy and Membrane Filtration N/A
Active, not recruiting NCT03213275 - The Premature Gut Microbiome and the Influence on Neonatal Immunity, Brain Development and White Matter Injury
Recruiting NCT03366090 - Immunological Profiles in Inflammatory Bowel Disease N/A
Completed NCT03609671 - Emotions Immunology and Breast Cancer N/A
Completed NCT00833651 - Protective Immunity Project 02 N/A
Recruiting NCT05480241 - Exocrine Pancreatic Insufficiency After Acute Pancreatitis and Pancreatic Enzyme Replacement Therapy N/A
Recruiting NCT05449028 - Helicobacter Pylori Eradication Therapy in Portugal N/A
Completed NCT05815615 - Plasmapheresis: a Multi-modal Approach N/A
Completed NCT01136395 - Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation Phase 2
Completed NCT00422838 - Study Investigating Immunological Effects of Treatment for Chronic Hepatitis C Patients. N/A
Recruiting NCT00167700 - Pre-, Peri- and Postnatal Programming and Origins of Disease: Early Targeting the Epidemics of Allergy and Overweight N/A
Recruiting NCT05368896 - Peri-operative Inflammaging in the Elderly After Surgery
Completed NCT04122222 - Immune Response to Influenza Vaccine in ESRD Patients N/A
Withdrawn NCT02441270 - Evaluation of the Immunological Effects of a Combined Treatment With Radiation and Cyclophosphamide in Metastasized Breast Cancer Patients Early Phase 1
Active, not recruiting NCT04974892 - Aspirin and Neutrophils in Preeclampsia